Share this article on:

Relationship Between Hyperglycemia and the Risk of Tuberculosis in Asian HIV-Positive Individuals in the Antiretroviral Therapy Era: Cohort Study

Achhra, Amit C. MBBS, MPH, PhD*; Pujari, Sanjay MD; Choi, Jun Yong MD; Khusuwan, Suwimol MD§; Van Kinh, Nguyen MD; Phanuphak, Praphan MD; Chaiwarith, Romanee MD#; Lee, Man Po MD**; Saphonn, Vonthanak MD††; Kiertiburanakul, Sasisopin MD‡‡; Thuy, Pham Thanh MD§§; Law, Matthew G. PhD*for the TREAT Asia HIV Observational Database (TAHOD) Cohort

JAIDS Journal of Acquired Immune Deficiency Syndromes: August 15th, 2014 - Volume 66 - Issue 5 - p e108–e111
doi: 10.1097/QAI.0000000000000217
Letters to the Editor

*Kirby Institute, UNSW Australia, Sydney, Australia

Ruby Hall Clinic, Pune, India

Yonsei University College of Medicine, Seoul, South Korea

§Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand

National Hospital for Tropical Diseases, Hanoi, Vietnam

HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand

#Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand

**Queen Elizabeth Hospital, Hong Kong, China

††National Center for HIV/AIDS, Dermatology and STDs, Phnom Penh, Cambodia

‡‡Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

§§Bach Mai Hospital, Hanoi, Vietnam

The TREAT Asia HIV Observational Database, TREAT Asia Studies to Evaluate Resistance, and the Australian HIV Observational Database are initiatives of TREAT Asia, a program of amfAR, The Foundation for AIDS Research, with support from the Dutch Ministry of Foreign Affairs through a partnership with Stichting Aids Fonds, and the U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and National Cancer Institute, as part of the International Epidemiologic Databases to Evaluate AIDS (U01AI069907). Queen Elizabeth Hospital and the Integrated Treatment Centre received additional support from the Hong Kong Council for AIDS Trust Fund. The Kirby Institute is funded by the Australian Government Department of Health and Ageing and is affiliated with the Faculty of Medicine, The University of New South Wales. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the governments or institutions mentioned above.

The authors have no conflicts of interest to disclose.

TAHOD-TASER study members are listed in Appendix.

© 2014 by Lippincott Williams & Wilkins